1.Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2018;154(2):360–73.
2.Lin C, Wang Y, Wang Y, Zhang S, Yu L, Guo C, et al. Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells. Oncogene. 2017;36(38):5392–406.
3.Li Q, Deng M, Xi M, Zhu Y, Hu Y. Characteristics and Treatment of Brain Metastases from Esophageal Squamous Cell Carcinoma. Journal of Cancer. 2018;9(5):901–5.
4.Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian journal of surgery. 2018;41(3):210–5.
5.Shinde SR, Gangula NR, Kavela S, Pandey V, Maddika S. TOPK and PTEN participate in CHFR mediated mitotic checkpoint. Cellular signalling. 2013;25(12):2511–7.
6.Liu Y, Liu H, Cao H, Song B, Zhang W, Zhang W. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis. Oncology reports. 2015;34(6):3288–96.
7.Ayllon V, O’Connor R. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene. 2007;26(24):3451–61.
8.Brown-Clay JD, Shenoy DN, Timofeeva O, Kallakury BV, Nandi AK, Banerjee PP. Erratum: PBK/TOPK enhances aggressive phenotype in prostate cancer via beta-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion. Oncotarget. 2016;7(2):2153–4.
9.Chang CF, Chen SL, Sung WW, Hsieh MJ, Hsu HT, Chen LH, et al. PBK/TOPK Expression Predicts Prognosis in Oral Cancer. International journal of molecular sciences. 2016;17(7).
10.Uchida E, Suwa S, Yoshimoto R, Watanabe K, Kasama T, Miura O, et al. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation. International journal of oncology. 2019.
11.Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The Protein Data Bank. Acta crystallographica Section D, Biological crystallography. 2002;58(Pt 6 No 1):899–907.
12.Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie DW. HexServer: an FFT-based protein docking server powered by graphics processors. Nucleic acids research. 2010;38(Web Server issue):W445–9.
13.Yao K, Peng C, Zhang Y, Zykova TA, Lee MH, Lee SY, et al. RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth. Proceedings of the National Academy of Sciences of the United States of America. 2017;114(48):12791–6.
14.Shaheen O, Ghibour A, Alsaid B. Esophageal Cancer Metastases to Unexpected Sites: A Systematic Review. Gastroenterology research and practice. 2017;2017:1657310.
15.Lin DC, Koeffler HP. Genomic lesions drive the metastasis of esophageal squamous cell carcinoma. Journal of thoracic disease. 2017;9(10):3523–4.
16.Abe Y, Matsumoto S, Kito K, Ueda N. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. The Journal of biological chemistry. 2000;275(28):21525–31.
17.Gaudet S, Branton D, Lue RA. Characterization of PDZ-binding kinase, a mitotic kinase. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(10):5167–72.
18.Wang WQ, Li R, Bai QX, Liu YH, Zhang WP, Wang JH, et al. Gossypol-Induced Differentiation in Human Leukemia HL–60 Cells. International journal of biomedical science: IJBS. 2006;2(4):395–401.
19.Dou X, Wei J, Sun A, Shao G, Childress C, Yang W, et al. PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation. Cancer cell international. 2015;15:27.
20.Zlobec I, Molinari F, Kovac M, Bihl MP, Altermatt HJ, Diebold J, et al. Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. British journal of cancer. 2010;102(1):151–61.
21.Ikeda Y, Park JH, Miyamoto T, Takamatsu N, Kato T, Iwasa A, et al. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2016;22(24):6110–7.
22.Luo Q, Lei B, Liu S, Chen Y, Sheng W, Lin P, et al. Expression of PBK/TOPK in cervical cancer and cervical intraepithelial neoplasia. International journal of clinical and experimental pathology. 2014;7(11):8059–64.
23.Shih MC, Chen JY, Wu YC, Jan YH, Yang BM, Lu PJ, et al. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. Oncogene. 2012;31(19):2389–400.
24.Zhu F, Zykova TA, Kang BS, Wang Z, Ebeling MC, Abe Y, et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology. 2007;133(1):219–31.
25.Xu M, Xu S. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis. Medicine. 2019;98(10):e14766.
26.Herbert KJ, Ashton TM, Prevo R, Pirovano G, Higgins GS. T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell death & disease. 2018;9(11):1089.
27.Gao T, Hu Q, Hu X, Lei Q, Feng Z, Yu X, et al. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer letters. 2019;445:11–23.
28.Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, et al. Inhibition of glycogen synthase kinase 3 beta (GSK3beta) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Molecular carcinogenesis. 2017;56(10):2301–16.
29.Xu FP, Liu YH, Luo XL, Zhang F, Zhou HY, Ge Y, et al. Overexpression of SRC–3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness. Cancer medicine. 2016;5(12):3500–11.
30.Goc A, Al-Husein B, Katsanevas K, Steinbach A, Lou U, Sabbineni H, et al. Targeting Src-mediated Tyr216 phosphorylation and activation of GSK–3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. Oncotarget. 2014;5(3):775–87.
31.Buxton RS, Magee AI. Structure and interactions of desmosomal and other cadherins. Seminars in cell biology. 1992;3(3):157–67.
32.Fang WK, Liao LD, Gu W, Chen B, Wu ZY, Wu JY, et al. Down-regulated gamma-catenin expression is associated with tumor aggressiveness in esophageal cancer. World journal of gastroenterology. 2014;20(19):5839–48.
33.Lie PP, Cheng CY, Mruk DD. The biology of the desmosome-like junction a versatile anchoring junction and signal transducer in the seminiferous epithelium. International review of cell and molecular biology. 2011;286:223–69.
34.Spindler V, Dehner C, Hubner S, Waschke J. Plakoglobin but not desmoplakin regulates keratinocyte cohesion via modulation of p38MAPK signaling. The Journal of investigative dermatology. 2014;134(6):1655–64.
35.Todorovic V, Desai BV, Patterson MJ, Amargo EV, Dubash AD, Yin T, et al. Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling. Journal of cell science. 2010;123(Pt 20):3576–86.